Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Cash Flows From Operating Activities
Net loss	$ 701,000	$ (3,798,000)	$ (16,416,000)	$ (1,518,000)	$ (679,000)	$ (17,899,000)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	68,000		50,000		192,000	147,000
Gain on sale of property and equipment					(70,000)
Gain on settlement of debt	(10,000)		48,000		(10,000)
Change in fair value of warrant derivative liability					(166,000)	3,517,000
Change in fair value of derivative liability	(1,080,000)		6,318,000		(1,324,000)	6,318,000	$ (984,000)
Loss on settlement of derivative	(47,000)		178,000		215,000	757,000
Loss on lease incentive					184,000
Accretion of debt discount					715,000	5,339,000
Change in operating assets and liabilities
Accounts receivable					(28,000)	145,000
Prepaid expenses and other current assets					4,000	113,000
Intangible digital assets					4,000	(5,000)
Other assets					3,000	(3,000)
Operating lease liability						1,000
Accounts payable					416,000	336,000
Accrued expenses					1,000	(95,000)
Contract liability					(30,000)	33,000
Security deposit					269,000	(140,000)
Net cash used in operating activities					(304,000)	(1,436,000)
Cash Flows From Investing Activities
Purchase of property and equipment						(68,000)
Net cash provided by (used in) investing activities						(68,000)
Cash Flows From Financing Activities
Proceeds from issuance of stock under lease agreement					220,000
Proceeds from convertible note payable						1,335,000
Proceeds from sale of stock under equity purchase agreement, net of issuance costs						228,000
Repayment of loan payable					(200,000)	(71,000)
Proceeds from notes payable, related party					20,000
Proceeds from loans payable						33,000
Net cash provided by financing activities					40,000	1,525,000
Net change in cash and cash equivalents					(264,000)	21,000
Cash and cash equivalents and restricted cash, beginning of period		$ 538,000		$ 1,230,000	538,000	1,230,000	1,230,000
Cash and cash equivalents and restricted cash, end of period	$ 274,000		$ 1,251,000		274,000	1,251,000	$ 538,000
Supplemental disclosure of cash flow information
Cash paid for interest
Cash paid for income tax
Non-cash investing and financing activities
Conversion of notes payable into common stock					140,000
Settlement of warrants with Common Stock					69,000
Cashless exercise of warrants and extinguishment of related warrant derivative liability					300,000	988,000
Discount related to convertible promissory note						1,500,000
Derivative liabilities related to convertible debt and warrants						6,761,000
Accounts payable settled with loan payable						$ 38,000